Latest Morphinans Stories

Grünenthal Group and Purdue Pharma L.P. Enter Into a Licensing Agreement

2013-05-28 12:27:36

AACHEN, Germany, May 28, 2013 /PRNewswire/ -- The Gruenenthal Group announced today that they have entered into a licensing agreement with Purdue Pharma L.P. regarding certain intellectual property rights for the development of an abuse-deterrent formulation technology for extended-release morphine sulfate. "We are excited about this licensing agreement with Purdue Pharma L.P. This is certainly another achievement that exemplifies our expertise, strength and innovative...

BioDelivery Sciences to Present at the Jefferies 2013 Global Healthcare Conference

2013-05-28 08:28:35

RALEIGH, N.C., May 28, 2013 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Jefferies 2013 Global Healthcare Conference. The presentation is scheduled for Tuesday, June 4, 2013 at 8:30 a.m. Eastern Time. (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO) Dr. Sirgo will provide an update on the status of the upcoming New Drug Application (NDA)...

Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry

2013-05-22 12:30:41

LEWIS CENTER, Ohio, May 22, 2013 /PRNewswire/ -- Modern Medical announced today the nationwide rollout of Opioid Defense Manager(TM) (ODM). Launched in November 2012 in a test phase, ODM is Modern Medical's revolutionary managed care program to stop the rising opioid abuse in the workers' compensation industry. ODM is a proactive, customized program designed to protect employees, physicians and employers by reducing inappropriate drug use while maintaining the necessary balance to...

Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain

2013-05-21 08:28:38

- Following major orthopedic surgery, Sufentanil NanoTab-treated patients experienced significantly greater reduction in pain as measured by SPID-48 vs. placebo (p

Codeine Addiction Treatment and Prescription Drug Rehab Center Announced by Recovery Associates

2013-05-20 23:23:19

Codeine Addiction Treatment and Prescription Drug Rehab Announced by Recovery Associates, Offering Support and Guidance for Those Addicted to Narcotic. WEST PALM BEACH, Florida (PRWEB) May 20, 2013 Recovery Associates, through its multiple therapeutic tracks, is placing an emphasis upon codeine addiction treatment, helping men and women break free from this harrowing and potent prescription drug. Codeine is a prescription pain reliever classified as an antitussive and opiate analgesic....

Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology

2013-05-20 08:27:59

ATLANTA, May 20, 2013 /PRNewswire/ -- Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical company that has developed and is commercializing a unique technology to deter prescription drug abuse today announced that its founder and President, Anthony Soscia, has been chosen as a finalist for the Atlanta Business Chronicle's Health-Care Heroes Awards. The awards are presented annually by the Atlanta Business Chronicle to honor individuals and organizations demonstrating excellence...

Opiate Withdrawal Fear Could Be Major Cause for Overdose Deaths; Pure Health Group Inc(TM) Provides New Rapid Response Release Technology Detox Solution to Prevent Deaths

2013-05-16 23:01:32

According to Pure Health Group, opiate Withdrawal is the biggest reason addicts remain addicts in our society and the flu-like symptoms which afflict a person going through withdrawal often cause a person to revert to their addiction and give up on getting clean. Subsequently, the overdose death rates have more than tripled in the last decade; Pure Health Group Inc.™ takes a stand and asks society to spread the word about their solution to prevent these deaths and the painkiller epidemic...

Erectile Dysfunction More Common in Men Who Regularly Take Prescription Painkillers

2013-05-15 12:34:35

Kaiser Permanente study first to use electronic health records to document link between prescription opioid use and ED prescriptions PORTLAND, Ore., May 15, 2013 /PRNewswire/ -- Regularly taking prescription painkillers, also known as opioids, is associated with a higher risk of erectile dysfunction, according to a study published online today in the journal Spine. The researchers included more than 11,000 men with back pain in the study and examined their health records to...

Heroin Addiction Treatment and Rehab Announced by Recovery Associates, Offering Drug Treatment for Those Addicted to Heroin or Morphine

2013-05-10 23:02:12

Recovery Associates expands emphasis on heroin addiction treatment programs. Numerous recovery tracks focus on addressing and stopping powerful drug addiction to heroin or morphine. Miami, Florida (PRWEB) May 10, 2013 Recovery Associates, through its multiple therapeutic tracks, is placing an emphasis upon heroin addiction treatment, helping men and women break free from this harrowing, potent drug. Heroin turns normal, functioning people into walking zombies and can leave them with...

Endo Health Solutions Responds to FDA's Denial of OPANA® ER Citizen Petition and the Potential Approval of Additional Non-Abuse Deterrent Formulations of Generic Oxymorphone

2013-05-10 16:25:10

MALVERN, Pa., May 10, 2013 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that the U.S. Food and Drug Administration (FDA) has denied a Citizen Petition filed by its subsidiary, Endo Pharmaceuticals Inc. Endo presented FDA data collected from an ongoing epidemiology study that indicate that per 100,000 prescriptions dispensed, the past 30-day abuse rate of crush-resistant OPANA ER was 79 percent lower than the abuse rate of generic versions of...